Studies with ZD1839 in preclinical models

被引：78

作者：

Sirotnak, FM

机构：

[1] Mem Sloan Kettering Canc Ctr, Lab Mol Therapeut, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA

来源：

关键词：

D O I：

10.1053/sonc.2003.50028

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：12 / 20

页数：9

共 50 条

[41]

SARUP JC, 1991, GROWTH REGULAT, V1, P72

[42]

Sato J D, 1983, Mol Biol Med, V1, P511

[43]

She Y., 2002, Proceedings of the American Association for Cancer Research Annual Meeting, V43, P786

[44]

Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885

[45]

SIROTNAK FM, 2000, P AM ASSOC CANC RES, V41, P482

[46]

Wells A, 2000, ADV CANCER RES, V78, P31

[47]

Williams Kaye J., 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P715

[48]

Woodburn J. R., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P633

Woodburn, JR .

[50]

Yang XD, 1999, CANCER RES, V59, P1236